REALEX PROPERTIES CORP.

Ajouter à une liste

Instrument Inactif

Autres langues Realex Properties Corp.

Actions

RP

CA7560415050

Cours en clôture Toronto S.E. Autres places de cotation
- ^CAD	-

Autres langues

16/02/16	Realex Properties : RepliCel Announces CEO Update
05/06/15	Realex Properties : RepliCel Life Sciences Announces Participation in 23rd World Congress of Dermatology, Vancouver, BC
21/05/15	Realex Properties : RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference
07/05/15	Realex Properties : RepliCel Life Sciences Selected to Present at Cavendish Global Health Impact Forum
29/04/15	Realex Properties : RepliCel Announces 2014 Fourth Quarter and Year-End Financial Results
15/04/15	Realex Properties : RepliCel Life Sciences Receives Approval to Conduct Clinical Trial for Patients with Chronic Achilles Tendinosis
08/04/15	Realex Properties : RepliCel Life Sciences Receives TSX Venture Exchange Approval to Extend Warrant Expiry Dates
02/04/15	Realex Properties : RepliCel Life Sciences Applies to Extend Warrant Expiry Dates
12/03/15	Realex Properties : RepliCel Life Sciences in Japan for Key Industry Meetings
20/01/15	Realex Properties : RepliCel Life Sciences to Present at 11th Annual Phacilitate Cell & Gene Therapy Forum in Washington, DC
07/01/15	Realex Properties : RepliCel Life Sciences to Present at Biotech Showcase 2015 in San Francisco
22/12/14	Realex Properties : Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness
10/11/14	Realex Properties : R. Lee Buckler: How RepliCel Is Harnessing the Awesome Power of Cell Therapy
02/10/14	Realex Properties : RepliCel to Present Clinical Trial Update at Stem Cell Meeting on the Mesa Partnering Forum in California
13/09/14	Realex Properties : RepliCel Retains Market-Making Services
20/05/14	Realex Properties : RepliCel Life Sciences' Licensing Partner, Shiseido, Opens Cell Processing and Expansion Facility in Japan to Advance RCH-01, a Treatment for Pattern Baldness
27/02/14	RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress of the Japanese Society for Regenerative Medicine

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

Tous les transcripts sur plus de 9000 sociétés, le jour de leur publication !

Débloquez-les Maintenant !

Débloquez-les Maintenant !

×